DXCM vs LEVI · P/E 63, rev $2.50B vs P/E 17, rev $3.30B
DexCom Inc (DXCM) versus Levi Strauss & Co Class A (LEVI) — a side-by-side from cached financials, not a winner call.
DexCom Inc (DXCM) is a medical devices company listed on US.
Levi Strauss & Co Class A (LEVI) is a apparel manufacturing company listed on NYSE.
Latest reported DXCM revenue for 2026-06-30 was $2.50B. Net income was $448.6M. DXCM currently screens at market cap $32.84B and trailing P/E 62.5.
Latest reported LEVI revenue for 2026-05-31 was $3.30B. Net income was $263.1M. Revenue was up 89.6% from 2026-03-01 to 2026-05-31. LEVI currently screens at market cap $9.00B and trailing P/E 17.2.
DXCM currently screens at market cap $32.84B and trailing P/E 62.5. LEVI currently screens at market cap $9.00B and trailing P/E 17.2.
Not investment advice. Open the DXCM and LEVI stock pages for the full models.
Not investment advice.